Successful Treatment with Octreotide of Spontaneous Chylothorax in a Premature Infant
- 29 January 2004
- journal article
- case report
- Published by Springer Nature in Journal of Perinatology
- Vol. 24 (3) , 194-195
- https://doi.org/10.1038/sj.jp.7211031
Abstract
A 2-month-old premature infant developed a spontaneous chylothorax. Medical therapy (chest tube drainage, parenteral alimentation) and thoracic duct ligation at 103 days of age had no effect. Drainage ceased during an octreotide infusion. The effusion recurred after octreotide was stopped, and responded completely to a longer course of therapy. Octreotide offers a substantial advantage over current medical management to some babies with spontaneous chylothorax.Keywords
This publication has 9 references indexed in Scilit:
- Treatment of persistent chylothorax after Norwood procedure with somatostatinThe Annals of Thoracic Surgery, 2002
- Initial Experience with Octreotide in the Pediatric PopulationClinical Journal of Sport Medicine, 2001
- Octreotide to treat postoperative chylothorax after cardiac operations in childrenThe Annals of Thoracic Surgery, 2001
- Octreotide for treatment of postoperative chylothoraxThe Journal of Pediatrics, 2001
- Somatostatin in the Treatment of ChylothoraxChest, 2001
- Treatment of a persistent postoperative chylothorax with somatostatinThe Annals of Thoracic Surgery, 1998
- Reduction of lymphorrhagia from ruptured thoracic duct by somatostatinThe Lancet, 1990
- Effect of Somatostatin on the Flow Rate and Triglyceride Levels of Thoracic Duct Lymph In Normal and Vagotomized DogsDiabetes, 1981
- TRAUMATIC CHYLOTHORAXJournal of Thoracic Surgery, 1948